Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.

Hirayama, Yasuo; Yoshida, Yoichiro; Mori, Masanori; Tamura, Kazuo

Hirayama, Yasuo; Yoshida, Yoichiro; Mori, Masanori; Tamura, Kazuo.

Affiliation

Hirayama Y; Department of Hematology Oncology, Higashi Sapporo Hospital, Sapporo, Japan.
Yoshida Y; Department of Gastroenterological Surgery, Fukuoka University, Fukuoka, Japan.
Mori M; Palliative Care Team, Seirei Mikatahara Hospital, Shizuoka, Japan.
Tamura K; General Medical Research Center, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Jpn J Clin Oncol ; 50(8): 897-902, 2020 Aug 04.

Article in En | MEDLINE | ID: mdl-32424420

Subject(s)

Antineoplastic Agents/adverse effects; Medical Oncology; Neoplasms/drug therapy; Peripheral Nervous System Diseases/chemically induced; Practice Guidelines as Topic; Specialization; Adult; Drugs, Chinese Herbal/therapeutic use; Duloxetine Hydrochloride/therapeutic use; Humans; Japan; Middle Aged; Peripheral Nervous System Diseases/drug therapy; Peripheral Nervous System Diseases/prevention & control; Surveys and Questionnaires

Key words

CIPN; JASCC; chemotherapy; guideline; neuropathy; questionnaire

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Specialization / Practice Guidelines as Topic / Peripheral Nervous System Diseases / Medical Oncology / Neoplasms / Antineoplastic Agents Limits: Adult / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Jpn J Clin Oncol Year: 2020 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google